Hindustan Bio Sciences Ltd Financials
Company Logo

Hindustan Bio Sciences Ltd Financial Statement

Hindustan Bio Sciences Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
RevenueTBA
Operating Expense0.05
Net Profit-0.05
Net Profit MarginTBA
Earning Per Share-0.05
EBIDTA-0.05
Effective Tax RateTBA
Invest in Hindustan Bio Sciences Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Hindustan Bio Sciences Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual1.05
Operating Expenses Annual0.99
Operating Profit Annual0.06
Interest Annual0.00
Depreciation0.01
Net Profit Annual0.06
Tax Annual-0.00

Hindustan Bio Sciences Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.01
Cash Flow from Operations-1.41
Cash Flow from InvestingTBA
Cash Flow from Financing1.43
Cash Flow at the End0.04

Hindustan Bio Sciences Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)5.71
PBIT Margin (%)4.76
PBT Margin (%)4.76
Net PROFIT Margin (%)5.71
Return On Networth / Equity (%)4.29
Return On Networth /Employed (%)1.53
Return On Assets (%)1.83
Total Debt / Equity (X)3.24
Asset Turnover Ratio (%)0.32

Hindustan Bio Sciences Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual0.03
Total Current Assets Annual0.95
Non Current Assets Annual2.42
Total Shareholders Funds Annual0.80
Total Assets Annual3.37

Hindustan Bio Sciences Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 26, 2024, Hindustan Bio Sciences Ltd has a market capitalization of 7.43 Cr. Value Research classifies it as a Micro-Cap company.
No, Hindustan Bio Sciences Ltd is not debt-free with a debt-to-equity ratio of 3.18.
In FY 2023 , Hindustan Bio Sciences Ltd recorded a total revenue of approximately 1.03 Cr marking a significant milestone in the company's financial performance.
Hindustan Bio Sciences Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.5% and 0.4% annually, respectively..
Hindustan Bio Sciences Ltd's current PE ratio is 123.83.
Hindustan Bio Sciences Ltd's ROCE averaged -5.5% from the FY ending March 2022 to 2024, with a median of -1.1%. It peaked at 1.7% in March 2024, reflecting strong capital efficiency over the period..
Hindustan Bio Sciences Ltd's latest EBIT is Rs. 0.05 Cr, surpassing the average EBIT of Rs. -0.16 Cr over the 5 years..